| Burden of migraine in Europe using self-reported digital diary data from the migraine buddy© application P Vo, N Paris, A Bilitou, T Valena, J Fang, C Naujoks, A Cameron, ... Neurology and therapy 7, 321-332, 2018 | 49 | 2018 |
| Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users Y Kato, W Poh, Z Horvath, F Cadiou, T Shimazu, Y Maruki BMC neurology 21, 1-7, 2021 | 15 | 2021 |
| Migraine factors as reported by smartphone users J Berengueres, F Cadiou 2016 38th Annual international conference of the IEEE engineering in …, 2016 | 9 | 2016 |
| Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application CC Chiang, X Fang, Z Horvath, F Cadiou, A Urani, W Poh, H Narimatsu, ... Neurology 101 (24), e2560-e2570, 2023 | 3 | 2023 |
| Real-world effectiveness of ubrogepant for the acute treatment of migraine when used in combination with an anti-calcitonin gene–related peptide monoclonal antibody preventive … AM Adams, J Contreras-De Lama, D Serrano, E Engstrom, W Poh, ... Neurology 98 (18 Supplement), 2022 | 3 | 2022 |
| Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE RB Lipton, J Contreras-De Lama, D Serrano, E Engstrom, ND Ayasse, ... Neurology and Therapy 13 (1), 69-83, 2024 | 2 | 2024 |
| COmbining UbRogepAnt and Preventives for MiGrainE (COURAGE) study using the migraine buddy application: a novel, entirely remote design for collecting real-world evidence RB Lipton, J Contreras-De Lama, D Serrano, E Engstrom, W Poh, ... JOURNAL OF HEADACHE AND PAIN 22 (SUPPL 1), 96-96, 2021 | 2 | 2021 |
| Evaluating the impact of migraine on work productivity in Switzerland using self-reported data from the Migraine Buddy (c) application N Paris, D Simsek, D Chandrasekhar, Y You, C Ferruzzi, F Cadiou, ... EUROPEAN JOURNAL OF NEUROLOGY 25, 232-232, 2018 | 2 | 2018 |
| PCR3 Real-World Effectiveness of Ubrogepant Among Participants with Prior Treatment Failure: Subgroup Analysis from the Universe Study A Shewale, W Poh, M Reed, J Liu, F Cadiou, K Burslem, R Lipton Value in Health 25 (7), S541, 2022 | 1 | 2022 |
| Real-world effectiveness of ubrogepant among participants with prior treatment failure: subgroup analysis from the UNIVERSE study (P12-2.001) AR Shewale, W Poh, ML Reed, J Liu, F Cadiou, K Burslem, ... Neurology 98 (18 Supplement), 2022 | 1 | 2022 |
| Treatment Satisfaction and Optimization With Real-World Use of Ubrogepant for the Acute Treatment of Migraine in Combination With an Anti-Calcitonin Gene–Related Peptide … J Contreras-De Lama, AM Adams, D Serrano, E Engstrom, W Poh, ... Neurology 98 (18 Supplement), 2022 | 1 | 2022 |
| Impact of an employer-provided migraine coaching program on patient burden and engagement L Schaetz, T Rimner, P Pathak, J Fang, F Cadiou, D Chandrasekhar, ... EUROPEAN JOURNAL OF NEUROLOGY 27, 306-306, 2020 | 1 | 2020 |
| A Comparison of Headache Assessment via Digital Platform in United States (HeAD-US) and American Migraine Prevalence and Prevention (AMPP) Studies: Baseline Demographics and … A Ezzati, K Fanning, A Urani, F Cadiou, R Lipton Neurology 102 (17_supplement_1), 6686, 2024 | | 2024 |
| Medication recommendation system and method for treating migraine NL Paris, FJS Cadiou, C Perret US Patent 11,791,047, 2023 | | 2023 |
| Evaluation of Timing of Migraine Attacks: A Big Data Approach P Goadsby, I Kizil, F Cadiou CEPHALALGIA 43 (1 supp), 2023 | | 2023 |
| Simultaneous Comparisons of 25 Acute Migraine Medications: A Big Data Analysis of 10 Million Patient Self-Reported Treatment Records From A Migraine Smartphone Application (S41 … CC Chiang, X Fang, Z Horvath, F Cadiou, A Urani, W Poh, H Narimatsu, ... Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| Medication recommendation system and method for treating migraine NL Paris, FJS Cadiou, C Perret US Patent 11,355,243, 2022 | | 2022 |
| Ubrogepant users' experience-Patients on Ubrogepant, characteristics and outcomes (UNIVERSE STUDY) AR Shewale, W Poh, ML Reed, S Manthena, F Cadiou, K Burslem, ... JOURNAL OF HEADACHE AND PAIN 22 (SUPPL 1), 20-21, 2021 | | 2021 |
| Impact of COVID-19 Pandemic on Migraine in Migraine Buddy Users Y Kato, W Poh, Z Horvath, F Cadiou, T Shimazu, Y Maruki | | 2021 |
| The Impact of Coronavirus Disease 2019 (Covid-19) Pandemic on Migraine Management (Face-to-Face Vs. Telehealth): Patients' Perspective F Haghdoost, C Delcourt, C Carcel, D Chandrasekhar, W Poh, F Cadiou, ... Cephalalgia, 27-27, 2020 | | 2020 |
